Label status: In January 2025, the Ozempic label was updated to state that it is not recommended in patients with severe gastroparesis, but does not indicate that the drug itself may cause the condition
They're incredibly effective, helping many achieve significant health improvements
In recent years, a class of drugs known as GLP-1 agonists have become wildly popular for patients seeking to lose weight
Weight reduction and reduced adiposity probably contributed significantly, but additional mechanisms may also be involved, such as improved insulin sensitivity, reduced inflammation, reduced aromatization for the adipose tissue, and potentially a restoration or improvement of the hypothalamic-pituitary-gonadal axis," he noted
Separate and combined gluco-metabolic effects of endogenous glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 in healthy individuals